Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will present at the RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2021, at 4:15 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will present at the RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2021, at 4:15 p.m. ET. This presentation will be streamed live and can be accessed via the company's investor relations page. Following the event, a replay will be available for 90 days. Wave Life Sciences is dedicated to developing innovative genetic medicines to treat severe diseases, utilizing its proprietary discovery platform, PRISM.
Details
News Market Reaction – WVE
The recorded move for WVE in the trading session of this news was -3.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer is scheduled to give a presentation at the RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 19, 2021 at 4:15 p.m. ET.
A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.